Trials / Conditions / Refractory T Lymphoblastic Lymphoma
Refractory T Lymphoblastic Lymphoma
3 registered clinical trials studyying Refractory T Lymphoblastic Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Ly NCT04315324 | SWOG Cancer Research Network | Phase 1 / Phase 2 |
| Active Not Recruiting | Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblast NCT03504644 | ECOG-ACRIN Cancer Research Group | Phase 1 / Phase 2 |
| Withdrawn | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase NCT02538926 | University of Washington | Phase 2 |